Wexford Capital logo

Wexford Capital

North America, Connecticut, United States, Greenwich

Description

Wexford Capital is an investment advisor which boasts $6.5 billion of assets under management.

Investor Profile

Wexford Capital has made 27 investments, with 1 in the past 12 months and 30% as lead.

Stage Focus

  • Series B (30%)
  • Series C (22%)
  • Series Unknown (11%)
  • Series A (11%)
  • Series D (7%)
  • Private Equity (7%)
  • Post Ipo Equity (7%)
  • Seed (4%)

Country Focus

  • United States (85%)
  • Canada (11%)
  • Israel (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical Device
  • Therapeutics
  • Manufacturing
  • Medical
  • Pharmaceutical
  • Renewable Energy
  • Health Diagnostics
  • Clean Energy
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wexford Capital frequently co-invest with?

Vulcan Capital
North America, Washington, United States, Seattle
Co-Investments: 2
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 4
GLG Partners
Europe, England, United Kingdom, London
Co-Investments: 2
Equus Total Return,Inc.
North America, Texas, United States, Houston
Co-Investments: 2
H
North America, California, United States, Irvine
Co-Investments: 4
Idealab
North America, California, United States, Pasadena
Co-Investments: 2
Invus
North America, New York, United States, New York
Co-Investments: 3
Emergent Medical Partners
North America, California, United States, Portola Valley
Co-Investments: 3
MF
North America, California, United States, Irvine
Co-Investments: 3
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 2

What are some of recent deals done by Wexford Capital?

Sailfish Royalty

Vancouver, British Columbia, Canada

Sailfish is a yield-focused royalty company.

Mining
Post Ipo EquityDec 3, 2024
Amount Raised: $198,770
Shape Memory Medical

Santa Clara, California, United States

Shape Memory Medical is a medical device company that develops innovative medical devices based on Shape Memory Polymer (SMP) materials.

Health CareMedical DeviceTherapeutics
Series CMar 4, 2024
Amount Raised: $38,000,000
Bonterra Resources

Val-d'or, Quebec, Canada

BonTerra is a Canadian gold exploration company with a large balanced portfolio of exploration and mining assets.

FinanceMineralMiningNatural Resources
Post Ipo EquityDec 15, 2020
Amount Raised: $11,811,535
Viseon

Irvine, California, United States

Viseon is a privately held medical device company committed to developing proprietary technology.

BiotechnologyClinical TrialsHealth CareMedical DeviceTherapeutics
Series BFeb 25, 2020
Amount Raised: $18,000,000
AZTherapies

Boston, Massachusetts, United States

AZTherapies is a clinical stage biotech company developing breakthrough treatments for neuroinflammation-related diseases.

BiopharmaBiotechnologyHealth CareNeurosciencePharmaceuticalTherapeutics
Series COct 17, 2019
Amount Raised: $26,300,000
Specialty Renal Products(SRP)

South Orange, New Jersey, United States

Specialty Renal Products(SRP) is a private medical device company.

Health CareMedical Device
Series ASep 6, 2018
Amount Raised: $3,000,000
Viseon

Irvine, California, United States

Viseon is a privately held medical device company committed to developing proprietary technology.

BiotechnologyClinical TrialsHealth CareMedical DeviceTherapeutics
Series ASep 26, 2017
Amount Raised: $5,000,000
Shape Memory Medical

Santa Clara, California, United States

Shape Memory Medical is a medical device company that develops innovative medical devices based on Shape Memory Polymer (SMP) materials.

Health CareMedical DeviceTherapeutics
Series BJul 28, 2017
Amount Raised: $7,000,001
Rebound Therapeutics

Irvine, California, United States

Rebound Therapeutics is a medical device company.

BiotechnologyMedical DeviceTherapeutics
Series BJul 25, 2017
Amount Raised: $16,500,000
ElMindA

Herzliya, Tel Aviv, Israel

ElMindA is a brain-tech company addressing the challenge of understanding the human brain, paving a path for better brain health.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series CNov 16, 2015
Amount Raised: $28,000,000